Source: International Congress 2015 – Immunodepression and severe pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Nils Hoyer (Copenhagen, Denmark), Nils Hoyer, Jørgen Vestbo. Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival. Eur Respir J 2015; 46: Suppl. 59, 2653

Member's Comments

No comment yet.

Related content which might interest you: Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Burden and impact of hospital-acquired infections in patients with chronic lung disease Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021 Chronic sinusitis may be one of the risk factors developing and deteriorating primary MAC pulmonary disease in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005 Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Source: Eur Respir J 2011; 37: 356 Year: 2011 Functional status in high and low risk patient with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD Year: 2013 Infection as a comorbidity of COPD Source: Eur Respir J 2010; 35: 1209-1215 Year: 2010 Mortality in COPD: role of comorbidities Source: Eur Respir J 2006; 28: 1245-1257 Year: 2006 Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016 Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Risk factors for pulmonary Mycobacterium avium-intracellulare complex disease deterioration in immunocompetent patients Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Chronic necrotizing aspergillosis, an emerging trend in clinical practice Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Risk factors for chronic obstructive pulmonary disease in women Source: Eur Respir J 2002; 20: Suppl. 38, 326s Year: 2002 Risk factors for active tuberculosis in patients with inflammatory bowel disease: A case-control study Source: International Congress 2015 – Latent TB infection and screening Year: 2015 High burden of A. fumigatus among chronic respiratory diseases Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016